NCT05649319

Brief Summary

This prospective, randomized, open-labeled study is designed to evaluate the impact of enhanced recovery after surgery (ERAS) protocol on postoperative quality of recovery in patients undergoing laparoscopic distal gastrectomy. We hypothesize that our ERAS protocol can significantly improve the postoperative quality of recovery in patients with laparoscopic distal gastrectomy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 28, 2022

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 14, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

February 3, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 7, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2024

Completed
Last Updated

January 1, 2025

Status Verified

December 1, 2024

Enrollment Period

1.3 years

First QC Date

November 28, 2022

Last Update Submit

December 30, 2024

Conditions

Keywords

Enhanced Recovery After SurgeryStomach NeoplasmsGastrectomyPain, Postoperative

Outcome Measures

Primary Outcomes (1)

  • Change of the Quality of recovery-15 during the first 72 hours after surgery

    Korean version of Quality of recovery-15 questionnaire (0-150): 0, "very poor recovery"; 150, "excellent recovery"

    postoperative 24, 48, and 72 hours

Secondary Outcomes (5)

  • Postoperative pain score

    postoperative 24, 48, and 72 hours

  • Total fentanyl consumption

    From the end of surgery to 24, 48, and 72 hours postoperatively

  • Postoperative nausea and vomiting

    From the end of surgery to 24, 48, and 72 hours postoperatively

  • Postoperative gastrointestinal dysfunction

    postoperative 24, 48, and 72 hours

  • Recovery time

    Evaluate every hour starting from 9A on the postoperative day 3 up to discharge

Study Arms (2)

ERAS group

EXPERIMENTAL

Perioperative care for laparoscopic distal gastrectomy is managed according to ERAS protocol.

Procedure: ERAS protocol

Conventional group

NO INTERVENTION

Perioperative care for laparoscopic distal gastrectomy is managed according to our current perioperative practice.

Interventions

ERAS protocolPROCEDURE

The ERAS protocol involves a pre-admission patient education using audiovisual videos, the reduction of perioperative fasting time with administration of preoperative carbohydrate loading and early resumption of oral feeding after surgery, multimodal postoperative nausea and vomiting prevention, early removal of the nasogastric tube and urinary catheter, and multimodal analgesia to minimize opioid consumption after surgery.

ERAS group

Eligibility Criteria

Age19 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled to undergo elective laparoscopic distal gastrectomy
  • American Society of Anesthesiologists (ASA)physical classification I-II
  • ECOG Performance Status Scale 0 or 1
  • Willingness and ability to sign an informed consent document

You may not qualify if:

  • Patients with chronic pain
  • Gastrectomy with combined resection of other organs
  • Patients with history of upper abdominal surgery
  • Allergies to anesthetic or analgesic medications (fentanyl, ropivacaine, acetaminophen, NSAIDs)
  • Medical or psychological disease that can affect the treatment response

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, KS013, South Korea

Location

MeSH Terms

Conditions

Stomach NeoplasmsPain, Postoperative

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Do Joong Park, MD, PhD

    Seoul National University Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A prospective randomized open-labeled study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 28, 2022

First Posted

December 14, 2022

Study Start

February 3, 2023

Primary Completion

June 7, 2024

Study Completion

August 30, 2024

Last Updated

January 1, 2025

Record last verified: 2024-12

Locations